Chinese herbal medicine may improve outcomes after STEMI
Por um escritor misterioso
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
A Chinese Drug Made of Insects May Help Cardiac Patients
Traditional Chinese medicine Tongxinluo may improve heart health
The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects
PDF) Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction, Chinese Medicine
GW25-e0861 Danhong Injection Antagonizes Adriamycin-Induced Cardiotoxicity from Oxidative Stress: Mechanism in vivo and in vitro
Part 9: Post–Cardiac Arrest Care
Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective - ScienceDirect
:max_bytes(150000):strip_icc()/Health-Berberine-Comp-7480908-Horiz-926589cfb89445f6a5dfb5f1a45aac85.jpg)
Berberine: Benefits, Uses, Side Effects, and More
Long-term cardiovascular outcomes of COVID-19
Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
